Biblio
Export 601 results:
Author Title Type [ Year
Filters: First Letter Of Keyword is D [Clear All Filters]
“O-GlcNAcylation and Its Roles in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1051-1068, 2024.
, “Optimizing the Implementation of a Lifestyle Dementia Prevention Intervention for Older Patients in an Academic Healthcare System.”, J Alzheimers Dis, vol. 100, no. 4, pp. 1237-1259, 2024.
, “Palliative Care in Nursing Home Residents with Young-Onset Dementia: Professional and Family Caregiver Perspectives.”, J Alzheimers Dis, vol. 97, no. 2, pp. 573-586, 2024.
, “Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
, “Pre-existing dementia is associated with 2-3 folds risk for in-hospital mortality and complications after intracerebral hemorrhage stroke.”, J Alzheimers Dis, vol. 102, no. 2, pp. 338-346, 2024.
, “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
, “Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.”, J Alzheimers Dis, vol. 99, no. 1, pp. 85-99, 2024.
, “Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.”, J Alzheimers Dis, vol. 99, no. s2, pp. S327-S344, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.”, J Alzheimers Dis, vol. 98, no. 1, pp. 265-274, 2024.
, “Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1751-1763, 2024.
, “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
, “There are dementia patients in Gaza too.”, J Alzheimers Dis, vol. 102, no. 2, pp. 317-320, 2024.
, “Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1421-1433, 2024.
, “Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.”, J Alzheimers Dis, vol. 98, no. 2, pp. 343-360, 2024.
, “Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease.”, J Alzheimers Dis, vol. 102, no. 2, pp. 424-436, 2024.
, “Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial.”, J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
, “Age-Related Association Between APOE ɛ4 and Cognitive Progression in de novo Parkinson's Disease.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1121-1132, 2023.
, “Association of Influenza Vaccination and Dementia Risk: A Meta-Analysis of Cohort Studies.”, J Alzheimers Dis, vol. 92, no. 2, pp. 667-678, 2023.
, “Best Medicine for Dementia: The Life-Long Defense of the Brain.”, J Alzheimers Dis, vol. 94, no. 1, pp. 51-66, 2023.
, “Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.”, J Alzheimers Dis, vol. 96, no. 1, pp. 113-124, 2023.
, “Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.”, J Alzheimers Dis, vol. 95, no. 3, pp. 931-940, 2023.
, “Characterizing Performance Gaps of a Code-Based Dementia Algorithm in a Population-Based Cohort of Cognitive Aging.”, J Alzheimers Dis, vol. 95, no. 3, pp. 931-940, 2023.
, “Chiral Amino Acid Profiling in Serum Reveals Potential Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. 1, pp. 291-301, 2023.
, “Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults.”, J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
,